Thromboembolism in ALK-rearranged Non-Small Cell Lung Cancer

We read with interest the article by Zer and colleagues, assessing rates of thromboembolism (TE) among patients with anaplastic lymphoma kinase rearranged (ALK+) Non Small-Cell Lung Cancer (NSCLC).1

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2uKuywy
via IFTTT